Evidence map

ArticleCardiovascular diabetology. Endocrinology reports2026

Trends in the use of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists among ischemic stroke patients.

Qinglan Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 41803896